Skip to main content

Table 1 Clinical characteristics of controls and patients

From: Lung CD4+ Vα2.3+ T-cells in sarcoidosis cohorts with Löfgren’s syndrome

 

Healthy controls

Non- sarcoidosis

LS

Non-LS

Subjects (n)

69

39

274

475

Gender M/F (n)

30/39

21/18

164/110

320/155

Age, yearsa

24 (18–56)

56 (23–78)

39 (21–72)

46 (24–78)

Never-smokers (n)

69

24

144

251

Lymphocytesb

6.0 (0.4–28.4)

22.5 (1.5–86.2)

23.9 (1.0–76.6)

26.7 (1.2–85.7)

CD4/CD8-ratioa

1.7 (0.3–6.4)

1.4 (0.2–3.2)

9.3 (0.4–56.8)

6.9 (0.4–46.0)

V-alfa 2.3b

4.5 (1.6–18.9)

5.3 (1.0–26.0)

21.2 (0.3–50.0)

6.4 (0.2–44.3)

  1. aValues are median (min-max). b Values are percentages of bronchoalveolar lavage cells (min-max). LS Löfgren’s syndrome. In 26 sarcoidosis patients there were no data about CD4/CD8-ratio. There were no data regarding smoking history in 2 LS patients and 3 non-LS patients